Multiple Sclerosis International
Overview
Multiple Sclerosis International is a scientific journal, published by Wiley since 2010 in English. The journal's country of origin is United States.
Details
Details
Abbr.
Mult Scler Int
Publisher
Wiley
Start
2010
End
2024
p-ISSN
2090-2654
e-ISSN
2090-2662
Country
United States
Language
English
Recent Articles
1.
Jaftha M, Robertson F, van Rensburg S, Kidd M, van Toorn R, Kemp M, et al.
Mult Scler Int
. 2024 Nov;
2024:8818934.
PMID: 39524062
: Cerebral white matter lesion (WML) formation in people with multiple sclerosis (pwMS) is linked to the death of myelin-producing oligodendrocytes. Current MS treatment strategies focus on limiting WML accumulation...
2.
Owlia F, Noori F, Zarchi M, Kazemipoor M
Mult Scler Int
. 2024 Sep;
2024:6662518.
PMID: 39295924
This study explores a relatively unexplored aspect of multiple sclerosis (MS) by examining the sensitivity threshold of dental pulp as a potential indicator of neuropathy in MS patients. Building upon...
3.
Buragadda S, Snow N, Gou A, McShane J, Newell C, Ploughman M
Mult Scler Int
. 2024 May;
2024:6055245.
PMID: 38721588
Purpose: The link between moderate- to vigorous-intensity physical activity (MVPA) and cardiorespiratory fitness in individuals with multiple sclerosis (MS) remains unclear. This study examined the relationship between self-reported MVPA and...
4.
Chylinska M, Komendzinski J, Wyszomirski A, Karaszewski B
Mult Scler Int
. 2023 Sep;
2023:4130557.
PMID: 37693228
Introduction: Currently, clinical trials of DMTs strive to determine their effect on neuroinflammation and neurodegeneration. We aimed to determine the impact of currently used DMTs on brain atrophy and disability...
5.
Takla T, Chargo A, Daugherty A, Fritz N
Mult Scler Int
. 2023 Aug;
2023:5582242.
PMID: 37600498
Purpose: Individuals with multiple sclerosis (MS) are at an increased fall risk due to motor and cognitive dysfunction. Our past studies suggest that backward walking (BW) velocity predicts fall risk;...
6.
Plummer P, Stewart A, Anderson J
Mult Scler Int
. 2023 Feb;
2023:1121051.
PMID: 36844028
Gait speed is frequently the primary efficacy endpoint in clinical trials of interventions targeting mobility in people with multiple sclerosis (MS). However, it is unclear whether increased gait speed is...
7.
Olfati H, Ghoshouni H, Ebrahimi N, Mohammadi A, Ghajarzadeh M
Mult Scler Int
. 2022 Dec;
2022:7091140.
PMID: 36536783
Background: Celiac disease (CD) is an autoimmune disease, and its prevalence reported variously in different studies. The goal of this study is to evaluate the pooled prevalence of CD in...
8.
Barzegar M, Houshi S, Sadeghi E, Hashemi M, Pishgahi G, Bagherieh S, et al.
Mult Scler Int
. 2022 Oct;
2022:9388813.
PMID: 36187599
Background: We conducted this study to assess the effect of disease-modifying therapies (DMTs) on coronavirus disease (COVID-19) susceptibility and severity in people with multiple sclerosis (MS). Methods: Available studies from...
9.
Binshalan T, Nair K, McNeill A
Mult Scler Int
. 2022 Jul;
2022:2357785.
PMID: 35860179
Background: People with Multiple Sclerosis (pwMS) prioritise gait as the most valuable function to be affected by MS. Physiotherapy plays a key role in managing gait impairment in MS. There...
10.
Arriaza M, Vazquez A, Hernandez T, Varillas-Delgado D, Meca-Lallana V
Mult Scler Int
. 2022 Jun;
2022:7908340.
PMID: 35754431
Functional rehabilitation programs in multiple sclerosis have demonstrated their efficacy in improving fatigue. The assessment of functional impairment, however, is more difficult. The purpose is to assess fatigue and disability...